Interplay between Candida albicans and the antimicrobial peptide armory

Area of Science:

• Immunology
• Mycology
• Antimicrobial Research

Background:

• Antimicrobial peptides (AMPs) are vital innate immune components targeting bacterial, viral, and fungal pathogens.
• Candida albicans, a medically significant fungus, exists as part of the human microbiota, with its proliferation tightly regulated by host immunity and fungal responses.
• Pathogen-associated molecular patterns (PAMPs) on fungi interact with pattern recognition receptors (PRRs) on human cells, initiating immune responses and AMP expression.

Purpose of the Study:

• To summarize the mechanisms by which human AMPs attack pathogenic fungi, particularly Candida albicans.
• To elucidate the strategies employed by Candida albicans to evade the effects of AMPs.
• To review current advancements in utilizing AMPs as antifungal agents against Candida albicans.

Main Methods:

• Review of existing literature on AMP-fungus interactions.
• Analysis of Candida albicans' resistance mechanisms against major AMP classes (cathelicidins, histatins, defensins).
• Examination of signaling pathways and environmental stimuli influencing fungal proliferation and AMP expression.

Main Results:

• Candida albicans employs a three-phase strategy to evade AMPs: secreting peptide effectors, utilizing AMP efflux pumps, and regulating signaling pathways.
• These evasion mechanisms confer basal resistance to major human AMP classes.
• Understanding these interactions is key to developing effective antifungal therapies.

Conclusions:

• Human AMPs are essential in controlling fungal pathogens like Candida albicans.
• Candida albicans has evolved sophisticated mechanisms to resist AMP-mediated immunity.
• Further research into AMPs holds promise for novel antifungal therapeutic strategies.